Folate Receptor Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is a recalcitrant malignancy with no available targeted therapy. Off target effects and poor bioavailability of the FDA approved anti-obesity drug orlistat hinder its clinical translation as a repurposed new drug against TNBC. Here we demonstrate a newly engineer...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Cancer Ther
Hoofdauteurs: Paulmurugan, Ramasamy, Bhethanabotla, Rohith, Mishra, Kaushik, Devulapally, Rammohan, Foygel, Kira, Sekar, Thillai V, Ananta, Jeyarama S, Massoud, Tarik F, Joy, Abraham
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747857/
https://ncbi.nlm.nih.gov/pubmed/26553061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0579
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items